Filing Details
- Accession Number:
- 0001110803-13-000238
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-06-17 20:03:08
- Reporting Period:
- 2013-06-12
- Filing Date:
- 2013-06-17
- Accepted Time:
- 2013-06-17 20:03:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1110803 | Illumina Inc | ILMN | Laboratory Analytical Instruments (3826) | 330804655 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1566173 | Michel Bouchard | 5200 Illumina Way San Diego CA 92122 | Vp, Finance | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-06-12 | 1,346 | $37.04 | 31,307 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-06-12 | 1,346 | $68.63 | 29,961 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2013-06-12 | 3,824 | $37.17 | 33,785 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-06-12 | 3,824 | $68.64 | 29,961 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2013-06-12 | 1,346 | $0.00 | 1,346 | $37.04 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2013-06-12 | 1,912 | $0.00 | 1,912 | $37.17 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2013-06-12 | 1,912 | $0.00 | 1,912 | $37.17 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 18,421 | 2010-02-27 | 2020-01-27 | No | 4 | M | Direct |
| 17,209 | 2009-03-24 | 2018-03-24 | No | 4 | M | Direct |
| 15,297 | 2009-03-24 | 2018-03-24 | No | 4 | M | Direct |
Footnotes
- The sale was made pursuant to a 10b5-1 plan.
- Weighted average sale price representing 1,346 shares sold ranging from $68.57 to $69.04 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 3,824 shares sold ranging from $68.58 to $69.04 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
Billionaire Hedge Funds
